{"id":4572,"date":"2023-11-28T10:35:09","date_gmt":"2023-11-28T02:35:09","guid":{"rendered":"https:\/\/regask.com\/?p=4572"},"modified":"2024-11-19T10:33:18","modified_gmt":"2024-11-19T02:33:18","slug":"essais-decentralises-en-argentine","status":"publish","type":"post","link":"https:\/\/regask.com\/fr\/argentina-decentralized-trials\/","title":{"rendered":"L&#039;ANMAT argentine propose des lignes directrices pour la gestion d\u00e9centralis\u00e9e des ressources naturelles."},"content":{"rendered":"<div class=\"ewa-rteLine\">\n<div class=\"ewa-rteLine\">\n<div class=\"ewa-rteLine\">\n<div class=\"ewa-rteLine\">\n<div class=\"ewa-rteLine\">Le guide ANMAT argentin d\u00e9crit les exigences relatives aux \u00e9l\u00e9ments d\u00e9centralis\u00e9s dans les \u00e9tudes de pharmacologie clinique, y compris les r\u00f4les et responsabilit\u00e9s du promoteur et des chercheurs, le consentement \u00e9clair\u00e9, la livraison des produits exp\u00e9rimentaux, les proc\u00e9dures d&#039;\u00e9tude, les logiciels de support et le stockage des donn\u00e9es cliniques.<\/div>\n<div class=\"ewa-rteLine\"><\/div>\n<div class=\"ewa-rteLine\"><\/div>\n<div class=\"ewa-rteLine\">Les exigences r\u00e9glementaires de l&#039;ANMAT\u2026<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t<div id=\"gap-656537056\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-656537056 {\n  padding-top: 60px;\n}\n<\/style>\n\t<\/div>\n\t\n\n\t<section class=\"section\" id=\"section_1980487123\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n<div class=\"row\"  id=\"row-279137791\">\n\n\t<div id=\"col-289012116\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n\t<section class=\"section\" id=\"section_1306795892\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n\n<div class=\"row\"  id=\"row-1485289622\">\n\n\n\t<div id=\"col-1863505962\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n<h2>D\u00e9sol\u00e9, ce contenu premium est r\u00e9serv\u00e9 aux clients RegASK uniquement.<\/h2>\n<p>Vous souhaitez acc\u00e9der \u00e0 l&#039;int\u00e9gralit\u00e9 du contenu de l&#039;alerte ou parcourir toutes les actualit\u00e9s ?\u00a0<\/p>\n<div class=\"row\"  id=\"row-688899805\">\n\n\n\t<div id=\"col-1990573029\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n<a href=\"https:\/\/app.RegASK.com\/#\/\" target=\"_blank\" class=\"button secondary is-outline\" rel=\"noopener\" >\n\t\t<span>Connexion client<\/span>\n\t<\/a>\n\n\n<a href=\"https:\/\/regask.com\/fr\/demander-une-demo\/\" class=\"button secondary lowercase\" style=\"border-radius:5px;\">\n\t\t<span>R\u00e9server une d\u00e9mo<\/span>\n\t<\/a>\n\n\n<a href=\"https:\/\/regask.com\/fr\/more-insights\/\" target=\"_blank\" class=\"button secondary is-outline\" rel=\"noopener\" >\n\t\t<span>Parcourir les actualit\u00e9s<\/span>\n\t<\/a>\n\n\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n<\/div>\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n<\/div>\n\n\t\t<\/div>\n\n\t\t\n<style>\n#section_1306795892 {\n  padding-top: 30px;\n  padding-bottom: 30px;\n  background-color: rgb(255,255,255);\n}\n<\/style>\n\t<\/section>\n\t\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>\n\t\t<\/div>\n\n\t\t\n<style>\n#section_1980487123 {\n  padding-top: 30px;\n  padding-bottom: 30px;\n  margin-bottom: -100px;\n  background-color: rgb(0, 49, 117);\n}\n<\/style>\n\t<\/section>\n\t\n\t<div id=\"gap-351479038\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-351479038 {\n  padding-top: 60px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>Argentina ANMAT guide outlines the requirements for decentralized elements in clinical pharmacology studies, including roles and responsibilities for the sponsor and investigators, Informed Consent, delivery of investigational products, study procedures, supportive software, and storage of clinical data. The regulatory requirements of ANMAT&#8230; &nbsp;<\/p>","protected":false},"author":39,"featured_media":4583,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[510,35],"tags":[139,137,56,40],"class_list":["post-4572","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-argentina-regulations","category-pharma-biotech-latest-insights","tag-decentralised-clinical-trial","tag-dct","tag-premium-news","tag-latest-insights"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.8 (Yoast SEO v27.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Argentina: Decentralized Clinical Trials | RegASK<\/title>\n<meta name=\"description\" content=\"ANMAT releases guidelines for decentralized clinical trials in Argentina. Stay informed with RegASK&#039;s expert analysis.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/fr\/essais-decentralises-en-argentine\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Argentina ANMAT proposes guidelines for decentralized clinical trials\" \/>\n<meta property=\"og:description\" content=\"ANMAT releases guidelines for decentralized clinical trials in Argentina. Stay informed with RegASK&#039;s expert analysis.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/fr\/essais-decentralises-en-argentine\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-28T02:35:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-19T02:33:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2021\/12\/food-with-trans-fat-fop-labelling.png\" \/>\n\t<meta property=\"og:image:width\" content=\"688\" \/>\n\t<meta property=\"og:image:height\" content=\"626\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Benoit Trouwaert\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2021\/12\/food-with-trans-fat-fop-labelling.png\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benoit Trouwaert\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/argentina-decentralized-trials\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/argentina-decentralized-trials\\\/\"},\"author\":{\"name\":\"Benoit Trouwaert\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\"},\"headline\":\"Argentina ANMAT proposes guidelines for decentralized c&hellip;\",\"datePublished\":\"2023-11-28T02:35:09+00:00\",\"dateModified\":\"2024-11-19T02:33:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/argentina-decentralized-trials\\\/\"},\"wordCount\":73,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/argentina-decentralized-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/DCT-Decentralised-Clinical-Trial.png\",\"keywords\":[\"Decentralised Clinical Trial\",\"DCT\",\"Premium News\",\"Latest Insights\"],\"articleSection\":[\"Argentina\",\"Pharma and Biotech\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/argentina-decentralized-trials\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/argentina-decentralized-trials\\\/\",\"name\":\"Argentina: Decentralized Clinical Trials | RegASK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/argentina-decentralized-trials\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/argentina-decentralized-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/DCT-Decentralised-Clinical-Trial.png\",\"datePublished\":\"2023-11-28T02:35:09+00:00\",\"dateModified\":\"2024-11-19T02:33:18+00:00\",\"description\":\"ANMAT releases guidelines for decentralized clinical trials in Argentina. Stay informed with RegASK's expert analysis.\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/argentina-decentralized-trials\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/regask.com\\\/argentina-decentralized-trials\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/DCT-Decentralised-Clinical-Trial.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/DCT-Decentralised-Clinical-Trial.png\",\"width\":330,\"height\":300,\"caption\":\"Dct Decentralised Clinical Trial\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\",\"name\":\"Benoit Trouwaert\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Argentine\u00a0: Essais cliniques d\u00e9centralis\u00e9s | RegASK","description":"L&#039;ANMAT publie des directives pour les essais cliniques d\u00e9centralis\u00e9s en Argentine. Restez inform\u00e9 gr\u00e2ce aux analyses d&#039;experts de RegASK.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/fr\/essais-decentralises-en-argentine\/","og_locale":"fr_FR","og_type":"article","og_title":"Argentina ANMAT proposes guidelines for decentralized clinical trials","og_description":"ANMAT releases guidelines for decentralized clinical trials in Argentina. Stay informed with RegASK's expert analysis.","og_url":"https:\/\/regask.com\/fr\/essais-decentralises-en-argentine\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2023-11-28T02:35:09+00:00","article_modified_time":"2024-11-19T02:33:18+00:00","og_image":[{"width":688,"height":626,"url":"https:\/\/regask.com\/wp-content\/uploads\/2021\/12\/food-with-trans-fat-fop-labelling.png","type":"image\/png"}],"author":"Benoit Trouwaert","twitter_card":"summary_large_image","twitter_image":"https:\/\/regask.com\/wp-content\/uploads\/2021\/12\/food-with-trans-fat-fop-labelling.png","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Benoit Trouwaert","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/argentina-decentralized-trials\/#article","isPartOf":{"@id":"https:\/\/regask.com\/argentina-decentralized-trials\/"},"author":{"name":"Benoit Trouwaert","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d"},"headline":"Argentina ANMAT proposes guidelines for decentralized c&hellip;","datePublished":"2023-11-28T02:35:09+00:00","dateModified":"2024-11-19T02:33:18+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/argentina-decentralized-trials\/"},"wordCount":73,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/argentina-decentralized-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2023\/11\/DCT-Decentralised-Clinical-Trial.png","keywords":["Decentralised Clinical Trial","DCT","Premium News","Latest Insights"],"articleSection":["Argentina","Pharma and Biotech"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/regask.com\/argentina-decentralized-trials\/","url":"https:\/\/regask.com\/argentina-decentralized-trials\/","name":"Argentine\u00a0: Essais cliniques d\u00e9centralis\u00e9s | RegASK","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/argentina-decentralized-trials\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/argentina-decentralized-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2023\/11\/DCT-Decentralised-Clinical-Trial.png","datePublished":"2023-11-28T02:35:09+00:00","dateModified":"2024-11-19T02:33:18+00:00","description":"L&#039;ANMAT publie des directives pour les essais cliniques d\u00e9centralis\u00e9s en Argentine. Restez inform\u00e9 gr\u00e2ce aux analyses d&#039;experts de RegASK.","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/argentina-decentralized-trials\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/regask.com\/argentina-decentralized-trials\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2023\/11\/DCT-Decentralised-Clinical-Trial.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2023\/11\/DCT-Decentralised-Clinical-Trial.png","width":330,"height":300,"caption":"Dct Decentralised Clinical Trial"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Le syst\u00e8me d&#039;exploitation d&#039;IA r\u00e9glementaire pour les \u00e9quipes performantes","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d","name":"Beno\u00eet Trouwaert"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts\/4572","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/users\/39"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/comments?post=4572"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts\/4572\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/media\/4583"}],"wp:attachment":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/media?parent=4572"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/categories?post=4572"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/tags?post=4572"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}